Violation Tracker Individual Record
Company:Insys Therapeutics, Inc.
Date:October 3, 2017
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Secondary Offense:kickbacks and bribery
Insys Therapeutics, Inc. agreed to pay $500,000 in settlement of allegations it unlawfully marketed its Fentanyl spray and paid kickbacks to persuade providers to prescribe the product.
Level of Government:state
Action Type:agency action
Agency:Massachusetts Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Arizona
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.